Major Players - Tamoxifen Industry

Jun, 2023 - by CMI

Major Players - Tamoxifen Industry

Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormone receptor positive, early stage of breast cancer after surgery to reduce the risk of recurrence.

Top Companies in the Tamoxifen Industry:

1) AstraZeneca Plc.

AstraZeneca Plc. Is a multinational pharmaceutical and biotechnology company. The company is known for manufacturing products for major diseases like Oncology, Cardiovascular, Infection, Respiratory and Inflammation. Apart from that, it has also been a part of developing the Oxford-AstraZeneca Covid-19 vaccine. The company was founded in 1999 and the headquarters are located in Cambridge, England, UK.

In July of 2021 AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc. In January of 2023, AstraZeneca also announced its plans to acquired CinCor a biopharmaceutical company based in the U.S.

2) Apotex Inc.

Apotex Inc. is a pharmaceutical corporation based in Canada. Apotex is the largest producer of generic drugs in Canada. The company manufactures and sells generic medications for diseases like cancer, diabetes, high cholesterol and blood pressure. The company was founded in the year 1974 and the headquarters are located in Toronto, Ontario, Canada. The company was founded by Barry Sherman.

In July, 2022 Apotex Inc. announced the launch of APO-Apixaban tablets. Canada’s first generic alternative to Eliquis. 

3) Allergan plc.

Allergan plc. is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox. Allergan was founded in the year 2013, and the headquarters are located in Dublin, Ireland.

4) Mylan N.V.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Products manufactured include Generic and Specialty pharmaceuticals and active pharmaceutical ingredients. The company was founded in the year 1961, by Milan Puskar and Don Panoz. The headquarters were located in Canonsburg, Pennsylvania, U.S.

As of April 2021, The Company announced, it had received approval for its bio similar of Humira, a drug used to treat a range of autoimmune diseases, from the European Commissions.

5) Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company Commission of autoimmune diseases, from the European. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva's facilities are located in Israel, North America, Europe, Australia, and South America. The company was founded in the year 1901, and the headquarters are located in Tel Aviv, Israel.

On 28 January 2020, the company announced that the Food and Drug Administration (FDA) had approved an autoinjector device for Ajovy (fremanezumab-vfrm) injection.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.